Epithelioid Hemangioendothelioma of Soft Tissue: A Proposal for Risk Stratification Based on 49 Cases

医学 上皮样血管内皮瘤 软组织 恶性肿瘤 单变量分析 血管肉瘤 纵隔 平滑肌肉瘤 软组织肉瘤 肉瘤 外科 放射科 病理 内科学 多元分析 免疫组织化学
作者
Andrea T. Deyrup,Mourad Tighiouart,Anthony Montag,Sharon W. Weiss
出处
期刊:The American Journal of Surgical Pathology [Lippincott Williams & Wilkins]
卷期号:32 (6): 924-927 被引量:311
标识
DOI:10.1097/pas.0b013e31815bf8e6
摘要

Epithelioid hemangioendothelioma (EHE) of soft tissue is a distinctive vascular tumor that has been variously considered a tumor of borderline malignancy and low-grade angiosarcoma. The majority of cases are associated with low mortality, but some metastasize and cause patient death. We analyzed 49 cases of EHE to determine if a method for stratifying risk for mortality could be developed. Fifty-one cases of EHE diagnosed during the period of 1989 and 2005 were retrieved. Tumors were evaluated with respect to location, size, cytologic atypia, mitotic activity, tumor cell spindling, and necrosis. Follow-up information was obtained for all cases. For actuarial analysis, disease-specific overall survival was evaluated using univariate and multivariable analysis. Most tumors occurred in adults (range, 9 to 93 y) and affected women predominantly (21 M:28 F). They developed in the head and neck (6), extremities (32), mediastinum (4), trunk (4), genitals (2), and retroperitoneum (1) and ranged in size from 0.5 to 18 cm. Clinical follow-up was obtained for all patients and ranged from 1.5 to 170 months (mean, 57.9 mo); 31 patients were alive without disease, 5 patients were alive with disease, 9 patients died of disease and 4 died of other causes. Overall 5-year disease-specific survival was 81%. Eleven patients (22%) had metastatic disease affecting lung (6), lymph node (4), liver (2), and bone, retroperitoneum, and soft tissue (1 each). Two patients had metastases to multiple sites. Treatment modality was known for 46 patients: 31 were treated surgically and 15 were treated with surgery and chemotherapy and/or radiation therapy. By univariate analysis, mitotic activity and size were associated with higher mortality (P=0.007 and 0.004, respectively). By multivariable analysis, increasing mitotic activity (P=0.00827, hazard ratio 10.03) and size (P=0.01, hazard ratio 2.26) were associated with decreased survival. Tumor site, cytologic atypia, the presence of necrosis, and tumor spindling were not significant. Those tumors with >3 mitotic figures/50 high power fields and size >3.0 cm had the worst prognosis (P=0.0002). Patients with high-risk tumors had a 5-year disease-specific survival of 59%; no patients with low-risk tumors died. In conclusion, we report that EHE can be stratified into 2 risk groups with markedly different clinical courses.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小可爱完成签到 ,获得积分10
刚刚
guangshuaiwu发布了新的文献求助20
刚刚
JamesPei的应助被细心青烟采纳,获得10
1秒前
桐桐的应助被smiling采纳,获得10
1秒前
酷波er的应助被crazzzzzy采纳,获得10
2秒前
2秒前
2秒前
卓初露完成签到 ,获得积分10
2秒前
2秒前
2秒前
WW完成签到,获得积分10
2秒前
酷波er的应助被VDC采纳,获得30
2秒前
Iridescent发布了新的文献求助10
2秒前
2秒前
Qiao的应助被搞怪白昼采纳,获得10
3秒前
3秒前
111完成签到,获得积分10
3秒前
h11的应助被MOMO9采纳,获得10
3秒前
桃子完成签到,获得积分20
3秒前
英俊的铭的应助被泡沫采纳,获得10
3秒前
4秒前
MeiLing发布了新的文献求助10
4秒前
8989完成签到,获得积分10
5秒前
5秒前
科研通AI2S的应助被龙九局采纳,获得10
5秒前
Franky发布了新的文献求助10
5秒前
5秒前
6秒前
清风明月入怀抱完成签到,获得积分10
6秒前
phoebe发布了新的文献求助10
6秒前
Ava的应助被包傲柔采纳,获得200
6秒前
门小楠发布了新的文献求助10
6秒前
小假完成签到,获得积分10
6秒前
文艺平文关注了科研通微信公众号
7秒前
molihuakai的应助被青橙采纳,获得10
7秒前
哈哈哈kk完成签到,获得积分10
7秒前
Shuan发布了新的文献求助10
7秒前
7秒前
xxx发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159663
求助须知:如何正确求助?哪些是违规求助? 9555211
关于积分的说明 21725494
捐赠科研通 7749713
什么是DOI,文献DOI怎么找? 3427292
关于科研通互助平台的介绍 2552372
邀请新用户注册赠送积分活动 2471628